Table 6.

Parameter changes after 0 (G0) and 21 (G21) days of treatment.

parameters	G0	G21	P	95%CI
FT4 (pmol/L)	11.58 ± 1.92	11.39 ± 2.28	0.363	-0.22~0.61
TSH (mIU/L)	2.40 ± 1.51	1.72 ± 0.61	<0.001	0.07~0.73
hsCR (mg/L) TC (mmol/L) TG (mmol/L) HDL (mmol/L) LDL (mmol/L) FFA (mmol/L) ApoA1 (g/L) ApoB (g/L) IL-2 IL-10 IL-6 IL-4 TNF-α LT4 (ug/L)	5.16 ± 3.71 6.31 ± 1.28 2.52 ± 1.14 2.23 ± 0.47 3.47 ± 1.01 0.37 ± 0.14 2.37 ± 0.41 1.28 ± 0.72 3.09 ± 2.86 3.76 ± 2.74 6.28 ± 4.40 3.92 ± 3.07 4.13 ± 3.59 50.89 ± 25.54	3.33 ± 1.71 5.56 ± 0.75 2.30 ± 1.08 2.11 ± 0.51 2.57 ± 0.57 0.36 ± 0.13 2.37 ± 0.41 1.40 ± 0.72 2.80 ± 2.35 3.76 ± 2.74 4.09 ± 2.60 4.20 ± 3.03 2.67 ± 2.61 48.88 ± 23.10	<0.001 <0.001 0.161 0.063 <0.001 0.526 0.924 0.428 0.990 0.929 <0.001 0.532 0.003 0.538	1.23~2.44 0.49~1.05 -0.09~0.51 -0.01~0.25 0.69~1.13 -0.20~0.04 -0.12~0.11 -0.28~0.12 -0.43~1.01 -0.74~0.73 1.12~3.26 -1.17~0.61 0.44~2.05 -4.40~8.42

FT4, free T4; TSH, thyroid stimulating hormone; HsCRP, serum hypersensitive C-reactive protein; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FFA, free fatty acid; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; LT4, levothyroxine.

P: p values of patients in the G0 group and G21 group.

p < 0.05 indicates statistical significance.